Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
Rx Supply Chain Progressing on EPCIS Adoption for DSCSA, Yet Challenges Still Remain
Updated survey data released today by the HDA Research Foundation indicate that healthcare supply chain partners remain in the formative stages of establishing the interoperable transaction data connections required to comply with the Drug Supply Chain Security Act (DSCSA) by November 27, 2023. However, some progress has been made since a previous survey conducted last spring.
A Dialogue on COVID-19 and the Future of the Healthcare Supply Chain
HDA recently sponsored and participated in the Milken Institute’s 2021 Future of Health Summit. This year’s event, held on June 22–23, brought together industry experts, public health leaders and elected officials for insightful policy discussions on a variety of issues that are shaping healthcare in our country.